腹膜透析联合血液透析治疗慢性肾功能衰竭的价值  

The Value of Peritoneal Dialysis Combined With Hemodialysis In The Treatment Of Chronic Renal Failure

作　　者：郭馨[1] 张东成[1] GUO Xin;ZHANG Dong-cheng(Department of Nephrology,Liaoning Provincial People’s Hospital,Liaoning Shenyang 110016)

机构地区：[1]辽宁省人民医院肾内科,辽宁沈阳110016

出　　处：《中国医疗器械信息》2021年第22期174-176,共3页China Medical Device Information

摘　　要：目的:研究对慢性肾功能衰竭患者应用腹膜透析联合血液透析治疗的临床价值。方法:抽选于2019年1月~2020年4月本院收治的慢性肾功能衰竭患者86例,根据抽签法均分为两组。对照组(n=43)接受腹膜透析治疗,研究组(n=43)接受腹膜透析+血液透析治疗。评价及对比两组的血液指标、肾功能指标、并发症率。结果:由血液指标变化上可见,治疗前,两组的Hb、Alb水平对比无明显差异性(P>0.05);治疗后,研究组的Hb、Alb水平高于对照组(P<0.05)。由肾功能指标变化上可见,治疗前,两组的Cre、BUN水平对比无明显差异性(P>0.05);治疗后,研究组的Cre、BUN水平低于对照组(P<0.05)。由并发症发生率上可见,研究组的并发症发生率低于对照组(P<0.05)。由生活质量水平中可见,治疗前两组生活质量对比差异不能满足统计学意义(P>0.05),经治疗后,研究组相比对照组较高(P<0.05)。结论:对慢性肾功能衰竭患者应用腹膜透析联合血液透析治疗,可提高免疫防护功能,改善患者肾功能,且不会增加并发症,提示安全性较高,同时能够对患者的生活质量进行提升,是一种理想的联合治疗方法。Objective:To study the clinical value of peritoneal dialysis combined with hemodialysis in patients with chronic renal failure.Methods:A total of 86 patients with chronic renal failure admitted to our hospital from January 2019 to April 2020 were selected and divided into two groups according to the lottery method.The control group(n=43)received peritoneal dialysis treatment,and the study group(n=43)received peritoneal dialysis+hemodialysis treatment.Evaluate and compare the blood indexes,renal function indexes,and complication rate of the two groups.Results:It can be seen from the blood index change data that before treatment,the Hb and Alb levels of the two groups were not significantly different(P>0.05);after treatment,the Hb and Alb levels of the study group were higher than those of the control group(P<0.05)).It can be seen from the changes in renal function index data that before treatment,there was no significant difference in the levels of Cre and BUN between the two groups(P>0.05);after treatment,the levels of Cre and BUN in the study group were lower than those in the control group(P<0.05).It can be seen from the complication rate data that the complication rate of the study group was lower than that of the control group(P<0.05).It can be seen from the quality of life level that the difference between the two groups of life treatment before treatment cannot meet statistical significance(P>0.05).After treatment,the study group is higher than the control group(P<0.05).Conclusion:The application of peritoneal dialysis combined with hemodialysis to patients with chronic renal failure can improve the immune protection function and improve the renal function of the patients without increasing complications,suggesting higher safety and improving the quality of life of the patients.It is an ideal combination therapy.

关 键 词：慢性肾功能衰竭 腹膜透析 血液透析 生活质量 

分 类 号：R692.5[医药卫生—泌尿科学]